Sean Salmon - 21 Feb 2024 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
21 Feb 2024
Net transactions value
-$492,934
Form type
4
Filing time
23 Feb 2024, 17:18:46 UTC
Previous filing
12 Dec 2023
Next filing
31 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $100,039 +1,594 +3.3% $62.76 49,833 21 Feb 2024 Direct F1
transaction MDT Ordinary Shares Options Exercise $820,022 +13,066 +26% $62.76 62,949 21 Feb 2024 Direct
transaction MDT Ordinary Shares Options Exercise $1,200,059 +16,035 +25% $74.84 78,984 21 Feb 2024 Direct
transaction MDT Ordinary Shares Sale $135,586 -1,594 -2% $85.06 77,390 21 Feb 2024 Direct
transaction MDT Ordinary Shares Sale $1,112,570 -13,066 -17% $85.15 64,324 21 Feb 2024 Direct F2
transaction MDT Ordinary Shares Sale $1,364,899 -16,035 -25% $85.12 48,289 21 Feb 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1,594 -11% $0.000000 13,066 21 Feb 2024 Ordinary Shares 1,594 $62.76 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -13,066 -100% $0.000000* 0 21 Feb 2024 Ordinary Shares 13,066 $62.76 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -16,035 -100% $0.000000* 0 21 Feb 2024 Ordinary Shares 16,035 $74.84 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person.
F2 The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
F3 The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.